News

Article

Quiz: ACR Guideline for the Treatment of Psoriatic Arthritis

Author(s):

The ACR's Psoriatic Arthritis Guidelines provides comprehensive recommendations for managing active psoriatic arthritis and aims to assist clinicians and patients in making informed decisions tailored to individual situations. Test your knowledge with this quiz.

The American College of Rheumatology 2018 Psoriatic Arthritis Guidelines provides comprehensive recommendations for managing active psoriatic arthritis (PsA) in treatment-naive patients and those with ongoing activity despite treatment. The guideline addresses various treatment options, including oral small molecules, tumor necrosis factor (TNF) inhibitors, interleukin-12/23 (IL-12/23) inhibitors, IL-17 inhibitors, and Janus kinase (JAK) inhibitors.

The guideline aims to assist healthcare providers and patients in making informed decisions tailored to individual situations, emphasizing it should not restrict treatment options for patients with PsA.

Test your knowledge of PsA treatment with this quiz:

In adult patients with active PsA and a history of frequent serious infections, both oral small molecule (OSM)- and biologic treatment-naive, what is the strongly recommended initial treatment choice according to the guideline?


Related Videos
Ben Samelson-Jones,Ben Samelson-Jones, MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Marlyn Mayo, MD: Improving Pruritus Management in PBC Care
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Highlighting the Danger of SCI Progression during iTTP Remission, with Shruti Chaturvedi, MBSS, MS
© 2024 MJH Life Sciences

All rights reserved.